Sex-Specific Differences in Antidepressant and Antipsychotic Treatment Outcomes and Serum Levels in Children and Adolescents

<b>Introduction:</b> Sex-specific differences in psychopharmacological treatment have gained increasing attention in adults, with studies showing that women often have higher serum concentrations of psychotropic drugs due to biological differences. However, despite recognition of these d...

Full description

Bibliographic Details
Published in:	Pharmaceutics
Main Authors:	Maike Scherf-Clavel, Stefanie Fekete, Manfred Gerlach, Christoph U. Correll, Paul Plener, Jörg M. Fegert, Andreas Karwautz, Peter Heuschmann, Tobias Banaschewski, Wolfgang Briegel, Christian Fleischhaker, Tobias Hellenschmidt, Hartmut Imgart, Michael Kaess, Michael Kölch, Karl Reitzle, Tobias J. Renner, Christian Rexroth, Gerd Schulte-Körne, Frank Theisen, Susanne Walitza, Christoph Wewetzer, Franca Keicher, Stefan Unterecker, Sebastian Walther, Marcel Romanos, Karin M. Egberts, Timo Vloet, Regina Taurines
Format:	Article
Language:	English
Published:	MDPI AG 2025-07-01
Subjects:	pharmacodynamics therapeutic drug monitoring psychotropic drugs adverse drug effects
Online Access:	https://www.mdpi.com/1999-4923/17/8/983

Similar Items

Off-label drug use in children and adolescents treated with antidepressants and antipsychotics: results from a prospective multicenter trial
by: Regina Taurines, et al.
Published: (2025-10-01)

Therapeutic drug monitoring of sertraline in children and adolescents: A naturalistic study with insights into the clinical response and treatment of obsessive-compulsive disorder
by: Elvira Tini, et al.
Published: (2022-05-01)

Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial
by: Michael Frey, et al.
Published: (2023-08-01)

Serum Concentration–Dose Relationship and Modulation Factors in Children and Adolescents Treated with Fluvoxamine
by: Regina Taurines, et al.
Published: (2024-06-01)

Risk reduction behaviours following the detection of unexpected drugs through community drug checking: a cross-sectional study
by: Samuel Tobias, et al.
Published: (2026-03-01)

Recreational Drug Overdose—Clinical Value of Toxicological Analysis
by: Tobias Zellner, et al.
Published: (2024-09-01)

A Physiologically-Based Pharmacokinetic (PBPK) Model Network for the Prediction of CYP1A2 and CYP2C19 Drug–Drug–Gene Interactions with Fluvoxamine, Omeprazole, S-mephenytoin, Moclobemide, Tizanidine, Mexiletine, Ethinylestradiol, and Caffeine
by: Tobias Kanacher, et al.
Published: (2020-12-01)

Systematic discovery of drug interaction mechanisms
by: Guillaume Chevereau, et al.
Published: (2015-04-01)

Episodic memories and their relevance for psychoactive drug use and addiction
by: Christian P. Müller
Published: (2013-05-01)

Impact of Anti-Mycotic Drugs on the Osteogenic Response of Bone Marrow Mesenchymal Stem Cells In Vitro
by: Tim Niklas Bewersdorf, et al.
Published: (2024-02-01)

Hydrogels as Drug Delivery Systems: A Review of Current Characterization and Evaluation Techniques
by: Margaux Vigata, et al.
Published: (2020-12-01)

Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption
by: Tobias Kanacher, et al.
Published: (2025-03-01)

Interpreting the Benefit and Risk Data in Between-Drug Comparisons: Illustration of the Challenges Using the Example of Mefenamic Acid versus Ibuprofen
by: André Farkouh, et al.
Published: (2022-10-01)

The rising use of cognitive enhancement drugs and predictors of use during COVID-19: findings from a cross-sectional survey of students and university staff in the UK
by: Jamie L. Tully, et al.
Published: (2024-07-01)

Discovery of Novel Symmetrical 1,4-Dihydropyridines as Inhibitors of Multidrug-Resistant Protein (MRP4) Efflux Pump for Anticancer Therapy
by: Henry Döring, et al.
Published: (2020-12-01)

Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional surveyResearch in context
by: Marie Antignac, et al.
Published: (2025-09-01)

A (des)informação sobre medicamentos: o duplo padrão de conduta das empresas farmacêuticas
by: José Augusto C. Barros

Medication error when switching from warfarin to rivaroxaban leading to spontaneous large ecchymosis of the abdominal and chest wall
by: Flavio Egger, et al.
Published: (2016-08-01)

Medication patterns and potentially inappropriate medication in patients with metastatic breast cancer: results of the BRE-BY-MED study
by: Lilly Sophia Brandstetter, et al.
Published: (2025-01-01)

Genome-wide associations spanning 194 in-hospital drug dosage change phenotypes highlight diverse genetic backgrounds in concurrent drug therapy
by: Alexander Pil Henriksen, et al.
Published: (2025-01-01)

CavitOmiX Drug Discovery: Engineering Antivirals with Enhanced Spectrum and Reduced Side Effects for Arboviral Diseases
by: Lena Parigger, et al.
Published: (2024-07-01)

The Prevalence of Potential Drug-Drug-Gene Interactions: A Descriptive Study Using Swiss Claims Data
by: Wittwer NL, et al.
Published: (2025-08-01)

Misuse of Anticholinergic Medications: A Systematic Review
by: Stefania Chiappini, et al.
Published: (2022-02-01)

Population-Based Assessment of Phenoconversion Potential in Switzerland: A Claims Data Study of Key Drug-Metabolizing Enzymes and Transporters
by: Roth MM, et al.
Published: (2026-05-01)

Toward More Open, Theoretically Grounded, and Sustainable Parental Involvement in Applied Behavior Analysis Interventions for Children with Autism Spectrum Disorder [Letter]
by: Chen S, et al.
Published: (2026-05-01)

Data-driven prediction of adverse drug reactions induced by drug-drug interactions
by: Ruifeng Liu, et al.
Published: (2017-06-01)

Engineering small molecule nanodrugs to overcome barriers for cancer therapy
by: Yuan Ma, et al.
Published: (2020-09-01)

Prevalence and Misreporting of Illicit Drug Use among Electronic Dance Music Festivals Attendees: A Comparative Study between Sweden and Belgium
by: Kristin Feltmann, et al.
Published: (2024-08-01)

pyHeart4Fish: Chamber-specific heart phenotype quantification of zebrafish in high-content screens
by: Viviana L. Vedder, et al.
Published: (2023-04-01)

In Vitro Activities of Dithiocarbamate Derivatives against <i>Echinococcus multilocularis</i> Metacestode Vesicles
by: Marc Kaethner, et al.
Published: (2023-12-01)

Targeting Loss of Heterozygosity: A Novel Paradigm for Cancer Therapy
by: Xiaonan Zhang, et al.
Published: (2021-01-01)

Drug–Drug–Gene Interactions in Cardiovascular Medicine
by: Asiimwe IG, et al.
Published: (2022-11-01)

IgE and Drug Allergy: Antibody Recognition of ‘Small’ Molecules of Widely Varying Structures and Activities
by: Brian A. Baldo
Published: (2014-01-01)

Potential drug-drug interactions in outpatients with depression of a psychiatry department
by: Yang Chen, et al.
Published: (2023-02-01)

An Open Access Database of Licensed Cancer Drugs
by: Pan Pantziarka, et al.
Published: (2021-03-01)

Editorial: Drug metabolism and transport: the Frontier of personalized medicine
by: Junmin Zhang, et al.
Published: (2023-07-01)

From the Criminalization of Substances to the “War on Drugs” Policy: A Century of Prohibitionism in Brazil
by: José Guilherme Magalhães e Silva, et al.
Published: (2024-06-01)

REDRESS AND CRIMINAL DEVIANCE IN USE OF DRUGS AND PSYCHOTROPIC SUBSTANCES IN ROMANIA
by: Bogdan MARINESCU
Published: (2018-05-01)

Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs
by: José Manuel Ezquerra-Aznárez, et al.
Published: (2021-11-01)

Potential drug interactions in adults living in the Brazilian Amazon: A population-based case-control study, 2019
by: Tayanny Margarida Menezes Almeida Biase, et al.
Published: (2021-09-01)